GVR Report cover U.S. & Canada Skin Cancer Dermatology Market Size, Share & Trends Report

U.S. & Canada Skin Cancer Dermatology Market Size, Share & Trends Analysis Report By Test Type (Skin Biopsy, Dermatoscopy), By Facility Type (Stand-alone, Hospitals), By Age Group, And Segment Forecasts, 2020 - 2027

  • Published Date: May, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68038-463-5
  • Format: Electronic (PDF)
  • Historical Data: 2016
  • Number of Pages: 116

Report Overview

The U.S. and Canada skin cancer dermatology market size was valued at over USD 1.4 billion and USD 0.4 billion respectively in 2019 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.2% and 6.3% respectively from 2020 to 2027. The growing prevalence of skin cancer is contributing largely to the growth. Furthermore, growing awareness among people about skin cancer and technological advancements in the dermatology field is also considered as the major driving factors.

U.S. skin cancer dermatology market size

According to the American Academy of Dermatology, in 2019, nearly 9,500 people in the U.S. were diagnosed with skin cancer each day. It is estimated that one in every five individuals in the U.S. is likely to be diagnosed with skin cancer in their lifetime. In Canada in the year 2019, nearly 7,800 residents were estimated to be diagnosed with melanoma and nearly 1,300 were estimated to have died due to melanoma. The high incident rate of melanoma in Canada and the U.S. is anticipated to fuel the demand for skincare dermatology.

The presence of organizations that aim to increase awareness regarding skin cancer and reduce its incidence rate is anticipated to fuel market growth. The American Academy of Dermatology (AAD) intends to reduce skin cancer-related incidence and mortality by educating the public about the techniques that aid in minimizing the risk of the disease and facilitate them in the identification of cancer or a potentially cancerous skin lesion. AAD also aims to set high clinical practice standards and undertake public awareness programs and research activities in the field dermatology to enhance patient care whereas the Canadian Dermatology Association aims to increase public awareness levels regarding sun protection and prevention of skin cancer.

Technology plays a key role in the clinical decision-making behavior of dermatologists. The introduction of teledermatology and the growing number of smartphone-compatible diagnostic devices has enabled the dermatologist to undertake remote patient diagnosis and monitoring, thus reducing the number of unnecessary office procedures. Furthermore, the EHR technology also enables dermatologists to select a cost-effective therapy for the patient.

Test Type Insights

Based on test type, the U.S. and Canada skin cancer dermatology market is segmented into skin biopsy, dermatoscopy, diagnostic imaging, and lymph node biopsy. Skin biopsy held the largest market share in 2019, attributed to the adoption of this procedure for the diagnosis of a wide range of skin conditions such as melanoma, skin infection, skin tags, dermatitis, basal cell carcinoma, and squamous cell carcinoma.

The diagnostic imaging segment is anticipated to grow at a rapid pace over the forecast period due to the introduction of advanced non-invasive techniques such as reflectance confocal microscopy (RCM) or optical coherence tomography (OCT), which have increased the accuracy of diagnosis. Furthermore, the combination of RCM with dermatoscopes is also expected to enhance the accuracy of diagnosis and aid in the differentiation between malignant and benign skin cancers.

Age Group Insights

On the basis of age group, the market for U.S. and Canada skin cancer dermatology is segmented into 0 to 19, 20 to 39, 40 to 59, 60 to 64, 65 to 74, 75 to 84, and 85 and above. The 40 to 59 age group segment accounted for more than 25% of the market share in 2019, due to the high prevalence of skin cancer in this age group. The high prevalence of skin cancer in this age group can be attributed to prolonged sun exposure. The 20 to 39 age group is anticipated to witness lucrative growth over the forecast period. This can be attributed to the popularity of tanning equipment and tanning salons among the individuals in this age group.

Facility Type Insights

Based on facility type, the market is segmented into stand-alone practices, multispecialty clinics, dermatology groups, hospital OPD, and others. Hospital OPD dominated the market share in 2019. The purchase of devices in large numbers accompanied by high demand for healthcare services and procedures in this setting is considered to play a vital role in the segment’s market share. The presence of public insurance systems and the availability of advanced technologies and procedures in hospitals is expected to be the main segment driver.

Canada skin cancer dermatology market share

Multispecialty clinics and dermatology groups held a relatively higher market share than solo practice in 2019. This can be attributed to rising costs and complexities of solo practice along with relatively higher dermatologist compensation in the group setting and higher bargaining power of group practice.

Key Companies & Market Size Insights

The key companies are concentrating on strategic initiatives such as geographical expansions and strategic collaborations. For instance, in 2019, MetaOptima signed a national agreement with Sonic Healthcare to implement DermEngine software across Australian skin cancer centers. Some of the prominent players in the U.S. and Canada skin cancer dermatology market include:

  • Firefly

  • SkinIO

  • Canfield Scientific, Inc.

  • FotoFinder Systems, Inc.

  • 3Gen

  • MetaOptima

  • Agilent Technologies

  • SkinVision

  • Speclipse, Inc.

  • Skin Analytics.

U.S. & Canada Skin Cancer Dermatology Market Report Scope

Report Attribute


Market size value in 2020

USD 1.43 billion in the U.S. & 0.4 billion in Canada

Revenue forecast in 2027

USD 2.2 billion in the U.S. & 0.7 billion in Canada

Growth Rate

CAGR of 5.2% in the U.S. and 6.3% in Canada from 2020 to 2027

Base year for estimation


Historical data

2016 - 2018

Forecast period

2020 - 2027

Quantitative units

Revenue in USD million/billion and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Test type, facility type, age group, and country

Regional scope

North America

Country scope

U.S. and Canada

Key companies profiled

Firefly; SkinIO; Canfield Scientific, Inc.; FotoFinder Systems, Inc.; 3Gen; MetaOptima; Agilent Technologies; SkinVision; Speclipse, Inc.; and Skin Analytics.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the U.S. and Canada skin cancer dermatology market report on the basis of test type, facility type, age group, and country:

  • Test Type Outlook (Revenue, USD Million, 2016 - 2027)

    • Skin Biopsy

    • Dermatoscopy

    • Diagnostic Imaging

    • Lymph Node Biopsy

  • Age Group Outlook (Revenue, USD Million, 2016 - 2027)

    • 0-19

      • Male

      • Female

    • 20-39

      • Male

      • Female

    • 40-59

      • Male

      • Female

    • 60-64

      • Male

      • Female

    • 65-74

      • Male

      • Female

    • 75-84

      • Male

      • Female

    • 85 & above

      • Male

      • Female

  • Facility Type Outlook (Revenue, USD Million, 2016 - 2027)

    • Stand Alone Practices

    • Multispecialty Clinics

    • Dermatology Group

    • Hospital OPD

    • Others

  • Country Outlook (Revenue, USD Million, 2016 - 2027)

    • The U.S.

    • Canada

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.